WHO's decision to resume HCQ clinical trial a step in right direction, say experts

The global heath body had earlier suspended the hydroxychloroquine (HCQ) arm of the clinical trials of experimental COVID-19 drugs over safety concerns. However on Wednesday, it recommended the trial to be continued following a review of safety data.
Source: The Economic Times - Category: Consumer Health News Source Type: news